Multicenter Experience with FRED Jr Flow Re-Direction Endoluminal Device for Intracranial Aneurysms in Small Arteries


Moehlenbruch M. A. , Kizilkilic O., Killer-Oberpfalzer M., Baltacioglu F. , Islak C., Bendszus M., ...More

AMERICAN JOURNAL OF NEURORADIOLOGY, vol.38, no.10, pp.1959-1965, 2017 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 38 Issue: 10
  • Publication Date: 2017
  • Doi Number: 10.3174/ajnr.a5332
  • Title of Journal : AMERICAN JOURNAL OF NEURORADIOLOGY
  • Page Numbers: pp.1959-1965

Abstract

The authors assessed the clinical safety and efficacy of the Flow Re-Direction Endoluminal Device Jr (FRED Jr) dedicated to small-vessel diameters between 2.0 and 3.0 mm in 42 patients with 47 aneurysms. The primary efficacy end point of complete or near complete occlusion was reached at 1 month in 27/41 (66%), at 6 months in 21/27 (78%), and at 12 months in 11/11 (100%) aneurysms.